|
April 4, 2011: Dr. Matthew Reynolds and Dr. C. Michael Gibson discuss: Lifetime Cost Effectiveness of Transcatheter Aortic Valve Implan |
Dr. Matthew Reynolds and Dr. C. Michael Gibson discuss: Lifetime Cost Effectiveness of Transcatheter Aortic Valve Implantation Compared with Standard Care among Inoperable Patients with Severe Aortic Stenosis: Results from the Randomized PARTNER Trial (Cohort B) at ACC 2011.
The PARTNER Trial was funded by a research grant from Edwards Lifesciences, Inc.
[ Download video ] |
|
No comments have been submitted
|